Shanghai Rightongene Biotechnology Co.Ltd(688217)
Independent directors on the second board of directors
Prior approval opinions on relevant matters of the fourth meeting
As an independent director of Shanghai Rightongene Biotechnology Co.Ltd(688217) (hereinafter referred to as the “company”) in accordance with the Listing Rules of Shanghai Stock Exchange, the rules for independent directors of listed companies and other laws, administrative regulations, departmental rules and normative documents, as well as the Shanghai Rightongene Biotechnology Co.Ltd(688217) articles of Association (hereinafter referred to as the “articles of association”), We hereby express the following prior approval opinions on the relevant matters of the fourth meeting of the second board of directors of the company:
1、 Proposal on re employment of accounting firm
As an independent director of the company, we learned the specific situation from the company’s management about the company’s proposed renewal of the accounting firm, and reviewed the relevant qualifications and other supporting materials of the proposed renewal of the accounting firm. Zhonghui Certified Public Accountants (special general partnership) is an accounting firm with securities related business qualification. It has the experience and ability to conduct annual audit of listed companies, and is objective and impartial in the company’s financial audit and internal control audit. The company plans to continue to employ an accounting firm, and there is no damage to the interests of the company and all shareholders. In order to ensure the continuity of the company’s audit business, we agree to submit the proposal on renewing the appointment of accounting firms to the fourth meeting of the second board of directors for deliberation.
Shanghai Rightongene Biotechnology Co.Ltd(688217) independent directors: Yuan Xuewei, Xu Weijian, Zhao Guiying April 15, 2022
